Interesting cancer study-investing implications

This may be too early stage to have a true impact for investments, but perhaps not. Obviously Kite and Juno have both been bought out already, so profitting from those has been locked in for many. Not sure if this treatment would have the possibility of eventually making the screening done by FMI obsolete.

Basically, it sounds like a simple injection of 2 things into a tumor can cause the rats’ immune systems to attack that tumor and any other cancers in their bodies or prevent future cancers. Sounds quite interesting and could be hugely beneficial if it could eventually be translated for human treatments.

https://med.stanford.edu/news/all-news/2018/01/cancer-vaccin…

4 Likes

thanks Volvan, definitely one I will follow. any advice on how to track it from the Stanford lab to the Startup?

I see that Saul, bulwinkl, and AJ (Phoolio) also found this study announcement to be interesting.